In a report released yesterday, Brian McNamara from Canaccord Genuity reiterated a Buy rating on EZCORP (EZPW – Research Report), with a price ...

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on TELA Bio (TELA – Research Report), with a ...

BCE (TSE:BCE – Free Report) (NYSE:BCE) had its target price decreased by Canaccord Genuity Group from C$33.50 to C$31.50 in a ...

TELUS (TSE:T – Free Report) (NYSE:TU) had its price target lowered by Canaccord Genuity Group from C$21.25 to C$20.25 in a ...

Key Insights Canaccord Genuity Group's significant individual investors ownership suggests that the key decisions ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

TORONTO - Canaccord Genuity Group Inc. has signed a deal to sell its U.S. wholesale market making business to Cantor as part ...

Fintel reports that on April 1, 2025, Canaccord Genuity initiated coverage of Arbe Robotics (NasdaqCM:ARBE) with a Buy ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of ...